RECLAIM
Trial
Recovering from COVID-19 Lingering Symptoms Adaptive Integrative Medicine
RECLAIM
RECLAIM is an adaptive platform randomized trial comparing the effectiveness of various interventions for lingering symptoms of COVID-19. Many doctors have seen an increase in patients with Long COVID or Post-COVID Condition.
Fatigue, shortness of breath with exertion, tachycardia, brain fog, insomnia/sleep disturbances, gastrointestinal disorders, skin rashes, anxiety and depression are some of the persisting symptoms. Our goal is to assess the efficacy of various interventions in the treatment of "long COVID"/Post-COVID Condition.
For more information on current interventions, please visit the Clinical Trials registry links below.
More intervention targets will be tested more quickly and efficiently
More diverse patient population and sites will be included
Strengthen our existing knowledge translation plans so that therapies found to be beneficial can be implemented quickly.
Open to Canadian residents ages 18 years of age or older with a history of COVID-19 and lingering symptoms for longer than 3 months.
The first two drug arm trials of the RECLAIM trial are now completed. The RECLAIM trial is now open to enrollment for the next round of intervention arms.
Studies | Description | Learn More | ClinicalTrails |
|---|---|---|---|
HBOT
Recruiting | This study is investigating whether hyperbaric oxygen therapy (HBOT) promotes healing in individuals with Long COVID. | https://www.reclaimtrial.ca/current-interventions | https://clinicaltrials.gov/study/NCT06452095 |
TaurineLC
Recruiting
| This study is investigating whether Taurine Supplementation can improve fatigue and neurocognitive symptoms in Long COVID. (TaurineLC, RECLAIM – TAURINE) | https://www.reclaimtrial.ca/current-interventions | https://clinicaltrials.gov/study/NCT06721949 |
Hi-OXSR
Recruiting | This study is exploring whether the Hi-OxSR device can help improve symptoms of post-COVID cognitive dysfunction, often described as “brain fog”. (RECLAIM - HiOxSR) | https://www.reclaimtrial.ca/current-interventions | https://clinicaltrials.gov/study/NCT06928506 |
Ibudilast and Pentoxifylline
(Enrollment Completed)
| This study is exploring whether the Hi-OxSR device can help improve symptoms of post-COVID cognitive dysfunction, often described as “brain fog”. (RECLAIM - HiOxSR) | https://classic.clinicaltrials.gov/ct2/show/NCT05513560 |
If you have any questions about our study or how to join, please contact us.
(1-866-673-2524)
%20(1).png){kind=logo}